Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $15,148 | $73,000 | $72,763 | $51,768 |
| - Cash | $2,903,915 | $2,608 | $2,622 | $4,784 |
| + Debt | $1,265 | $129 | $242 | $477 |
| Enterprise Value | -$2,887,502 | $70,521 | $70,383 | $47,461 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$11 | -$13 | -$12 | -$4 |
| % Margin | – | – | – | – |
| EBITDA | -$91 | -$2,142 | -$2,706 | -$2,244 |
| % Margin | – | – | – | – |
| Net Income | -$102 | -$2,782 | -$3,733 | -$4,028 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.005 | -0.14 | -0.19 | -0.28 |
| % Growth | 96.6% | 26.3% | 32.1% | – |
| Operating Cash Flow | -$181 | -$2,126 | -$2,964 | -$741 |
| Capital Expenditures | -$1 | -$74 | -$213 | -$1,312 |
| Free Cash Flow | -$182 | -$2,200 | -$3,176 | -$2,054 |